navigation
total 1563 publications found
filter by journal
| view | year | title | authors |
|---|---|---|---|
| 2026 | Association of a polygenic risk score with low trauma fractures in people with HIV - The swiss HIV cohort study. | Hasse B; Ryom L; Thurnheer MC; Fux C; Kahlert CR; Bernasconi E; Calmy A; Lamy O; Gunthard HF; Ledergerber B; Fellay J; Tarr PE; Strickler C; Thorball CW; Schoepf IC; Schwenke J; and the Swiss HIV Cohort Study | |
| 2026 | Low Trauma Fractures in People With HIV: Longitudinal Time Trends in the Swiss HIV Cohort Study, 2009-2022. | Schoepf IC; Baltisberger V; Thorball CW; Ryom L; Wandeler G; Haerry D; Kahlert CR; Bernasconi E; Calmy A; Lamy O; Fellay J; Gunthard HF; Ledergerber B; Tarr PE; and the Swiss HIV Cohort Study | |
| 2026 | Association of leukocyte count with death in people with HIV: A longitudinal study over 24 years. | Klein Z; Meyer SC; Schoepf IC; Weber M; Thorball CW; Ryom L; Kootstra NA; Reiss P; Braun DL; Thurnheer MC; Marzolini C; Kahlert CR; Bernasconi E; Cavassini M; Marinosci A; Fellay J; Kouyos RD; Gunthard HF; Ledergerber B; Tarr PE; and the Swiss HIV Cohort Study | |
| 2026 | Cancer burden and risk factors among women with HIV: a multi-regional study from the D:A:D and RESPOND cohort collaborations. | Han WM; Neesgaard B; Knappik M; Cavassini M; Abela IA; Timiryasova A; Greenberg L; Martin C; Mussini C; Wit F; Sabin C; Castagna A; Abutidze A; El-Sadr W; Bonnet F; Sarcletti M; Carlander C; Hachfeld A; Weis N; Vannappagari V; Rogatto FP; Young LA; Hosein SR; Ryom L; Petoumenos K; and the Swiss HIV Cohort Study | |
| 2026 | Circulating HBV RNA and hepatitis B core-related antigen as determinants of HBsAg loss in persons with HIV in Europe. | Begre L; Boyd A; Plissonnier ML; Testoni B; Beguelin C; Suter-Riniker F; Scholtes C; Rockstroh JK; Lacombe K; Peters L; Heil M; Levrero M; Rauch A; Zoulim F; Wandeler G; and the Swiss HIV Cohort Study | |
| 2026 | Improving cohort coverage estimation using a data triangulation framework: the Swiss HIV Cohort Study example. | Tschopp J; Wandeler G; Rauch A; Gunthard HF; Kusejko K; Duran Ramirez JJ; Kouyos RD; Abela I; Beguelin C; Bongiovanni M; Bruggmann P; Calmy A; Cavassini M; Cusini A; de Roche M; Elzi L; Friedl A; Fulchini R; Fux C; Haerry D; Hampel B; Herold M; Kaiser P; Kovari H; Schmid P; Sculier D; Stockle M; Tarr PE; Tissot F; and the Swiss HIV Cohort Study | |
| 2026 | Offer of a menu of different nicotine substitute products to REduce Tobacco Use iN pEople living with HIV (RETUNE): a protocol for a pragmatic randomized trial within the Swiss HIV Cohort Study. | Schonenberger CM; Speich B; Zehnder ER; Haerry DH; Cart-Richter E; Jackson-Perry D; Hutter A; Aggeler S; Steinmann J; Chaudron SE; Calmy A; Cavassini M; Braun D; Fux CA; Abela I; Kusejko K; Gunthard HF; Nemeth J; Rauch A; Wandeler G; Schmid P; Dorr T; Notter J; Weisser Rohacek M; Surial B; Berthet A; Auer R; Stoeckle MP; Labhardt N; Chammartin F; Briel M; Amstutz A; and the Swiss HIV Cohort Study | |
| 2026 | Do people with HIV really have the choice between oral and injectable ART? Evidence from a multicentric survey in the Swiss HIV cohort study. | Martin Y; Surial B; Muller M; Baumann L; Jackson-Perry D; Haerry D; Ballif M; Beguelin C; Burgi M; Munting A; Cavassini M; Braun D; Rauch A; Auer R; Wandeler G; and the Swiss HIV Cohort Study | |
| 2026 | Dosing of ritonavir-boosted darunavir for treatment of HIV in pregnancy. | Sconza R; Taylor GP; Ene L; Kahlert C; van der Wekken-Pas L; Renaud F; Thorne C; Townsend CL; and the Swiss HIV Cohort Study | |
| 2026 | Chronic alanine aminotransferase elevation in people with HIV: Time trends over 22 years and genetic predisposition. | Simon NR; Mondoka C; Thorball CW; Schoepf IC; Ryom L; Abela I; Beguelin C; Fuhrer U; Kovari H; Marzolini C; Marinosci A; Kahlert C; Elzi L; Haerry D; Cavassini M; Ledergerber B; Fellay J; Wandeler G; Tarr PE; and the Swiss HIV Cohort Study | |
| 2026 | Viral heritability of neurocognitive performances in persons living with HIV and underlying viral residue variants. | Zeeb M; Bieler-Aeschlimann M; Frischknecht P; Neumann K; Jorimann L; Tschumi J; Huber M; Kusejko K; Bernasconi E; Kovari H; Leuzinger K; Notter J; Perreau M; Staehelin C; Ramette A; Stockle M; Yerly S; Calmy A; Metzner KJ; Gunthard HF; Cavassini M; Kouyos RD; and the Swiss HIV Cohort Study | |
| 2026 | Switching to Integrase Inhibitors and Cardiovascular Disease Risk in Treatment-Experienced People With HIV: A Sequential Target Trial Emulation in the Swiss HIV Cohort Study. | Lee TT; Cavassini M; Marinosci A; Haerry D; Stockle M; Schmid P; Elzi L; Fux CA; Tarr PE; Baumann L; Gunthard HF; Wandeler G; Labhardt ND; Surial B; Chammartin F; and the Swiss HIV Cohort Study | |
| 2026 | Cardiovascular Disease Risk with Integrase Inhibitor-based Antiretroviral Therapy: A Causal Inference Analysis in RESPOND. | Surial B; Neesgaard B; Chammartin F; Ryom L; Petoumenos K; Reekie J; Paredes R; Zangerle R; Smith C; Martin C; Wit F; Jaschinski N; Mussini C; d'Arminio Monforte A; Castagna A; Carlander C; Hetman L; Sohani E; Lehmann C; Hosein SR; Van Wyk JA; Bissio E; Lundgren J; Rauch A; Gunthard HF; Wandeler G; Greenberg L; and the Swiss HIV Cohort Study | |
| 2026 | Outcomes for persons with triple-class resistant HIV and a history of virologic failure. | Ingle SM; Bonnet F; Wittkop L; Calmy A; Teira R; Rebeiro PF; Crane HM; Stephan C; van der Valk M; Boesecke C; Touloumi G; Gill MJ; Grabmeier-Pfistershammer K; Garcia F; Ceccherini-Silberstein F; Burkholder G; Trickey A; Sterne JAC; Hessamfar M; and the Swiss HIV Cohort Study | |
| 2026 | CD4 + cell count trends after common cancers in people with HIV: a multicohort collaboration. | Domingo P; Tarr PE; Egle A; Martin C; Mussini C; Wit F; Cingolani A; Lehmann C; Castagna A; Petoumenos K; Sabin CA; Borges A; El-Sadr W; Lundgren J; Hosein S; Carlander C; Amstutz A; Grabmeier-Pfistershammer K; Garges H; Marongui A; Young LA; Peters L; Ryom L; Timiryasova A; Greenberg L; and the Swiss HIV Cohort Study | |
| 2026 | Trends in AIDS-defining illnesses among people living with HIV in clinical care in Europe: results from the EuroSIDA multicentre cohort study (2003-24). | Bannister WP; Reekie J; Peters L; Oprea C; Matulionyte R; Scheerder MA; Kryshchuk A; Rasmussen LD; Burns F; Zilmer K; Jablonowska E; Boesecke C; Zagalo A; Martinez E; Stoeckle M; Szlavik J; Cetkovic JT; Adamis G; Kowalska JD; Podlekareva D; and the Swiss HIV Cohort Study | |
| 2026 | Acceptance and preferences for different nicotine substitute products to reduce tobacco smoking in people living with HIV: Results from an internal pilot study of a randomized trial. | Schonenberger CM; Ochoa SC; Speich B; Haerry DH; Cart-Richter E; Jackson-Perry D; Hutter A; Panettieri L; Aggeler S; Chaudron SE; Calmy A; Cavassini M; Abela IA; Kusejko K; Gunthard HF; Nemeth J; Rauch A; Wandeler G; Schmid P; Dorr T; Surial B; Berthet A; Auer R; Stoeckle MP; Labhardt N; Chammartin F; Briel M; Amstutz A; and the Swiss HIV Cohort Study | |
| 2026 | Risk of Hepatocellular Carcinoma After Direct-Acting Antiviral Treatment for Hepatitis C Virus Infection in People With HIV. | van Santen DK; Chalouni M; Berenguer J; Jarrin I; Miro JM; Klein MB; Young J; Torgersen J; Rentsch CT; Gill MJ; Epstein RL; Nunes D; Surial B; Rauch A; Touloumi G; Papadopoulos A; Wittkop L; Gilbert C; Leleux O; van der Valk M; Boyd A; Monforte AD; Puoti M; Zangerle R; Gisinger M; Logan RW; Rein S; Hernan MA; Lodi S; and the Swiss HIV Cohort Study | |
| 2026 | Multiancestry Genome-Wide Association Study Identifies Variants in a Zinc Finger Gene Cluster as Novel Regulators of HIV Control. | Awada A; Tough RH; Fellay J; McLaren PJ; and the Swiss HIV Cohort Study | |
| 2026 | Risk of type 2 diabetes mellitus after treatment with direct-acting antivirals for hepatitis C virus in people with HIV. | Chalouni M; Torgersen J; Rentsch CT; Van Santen DK; Jarrin I; Klein MB; Young J; Gill MJ; Epstein RL; Linas B; Zangerle R; Surial B; Nemeth J; Touloumi G; Papadopoulos A; Wittkop L; Van Der Valk M; Boyd A; Monforte AD; Puoti M; Logan RW; Rein SM; Miro JM; Berenguer J; Hernan MA; Lodi S; and the Swiss HIV Cohort Study | |
| 2026 | Similar Changes in Proviral Landscapes Over 10 Years in 40 Individuals With Diverging HIV Reservoir Dynamics and Viral Load Kinetics. | Tschumi J; Jorimann L; Zeeb M; Neumann K; Stockle M; Bernasconi E; Yerly S; Cavassini M; Rauch A; Schmid P; Kouyos RD; Gunthard HF; Metzner KJ; and the Swiss HIV Cohort Study | |
| 2026 | Novel integrase mutations linked to genotypic DTG resistance in African non-B HIV-1 strains: the DTG RESIST study. | Han N; Loosli T; Sauermann M; Celikag I; Anderegg N; Baye BC; Bolton Moore C; Buzaalirwa L; Byakwaga H; Chimbetete C; Ebasone PV; Goodrich S; Huwa J; Kasozi C; Mafoua A; Massamba AC; Messou E; Minga A; Murenzi G; Muula G; Muyindike W; Naidoo SJ; Nsonde DM; Poda AG; Ramde R; Semeere A; Singh L; Gunthard HF; Egger M; Giandhari J; Lessells R; Kouyos RD; and the Swiss HIV Cohort Study | |
| 2026 | Genetic determinants of HIV-1 elite control. | Ryan B; Fellay J; Thorball CW; and the Swiss HIV Cohort Study | |
| 2026 | Behavioural trajectories following DAA treatment for HCV among people with HIV: findings from an international consortium of prospective cohort studies. | Hage K; Carson J; Hosseini-Hooshyar S; Sacks-Davis R; Stewart AC; Van Santen DK; Smit C; Van Der Valk M; Wittkop L; Klein MB; Doyle JS; Rauch A; Matthews GV; Hellard ME; Boyd A; Prins M; and the Swiss HIV Cohort Study | |
| 2025 | Viremia Does Not Independently Predict Cardiovascular Disease in People With HIV: A RESPOND Cohort Study. | Elvstam O; Ryom L; Neesgaard B; Tau L; Gunthard HF; Zangerle R; Vehreschild JJ; Wit F; Sonnerborg A; Kovari H; Abutidze A; Petoumenos K; Jaschinski N; Hosein S; Bogner J; Grabmeier-Pfistershammer K; Garges H; Rooney J; Young L; Law M; Kirk O; and the Swiss HIV Cohort Study |